This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses)

Brussels - UNIV UZ Brussel, Brussels

Edegem - UNIV UZ Antwerpen, Edegem

Bonheiden - HOSP Imelda, Bonheiden

Centre Hospitalier Universitaire de Liège, Liège

UNIV UZ Gent, Ghent

Quinta Analytica, Prague

Scott Research, Inc., Laurelton

CTC North GmbH & Co. KG, Hamburg, Hamburg

York Clinical Research, LLC, Norfolk

PMG Research of Wilmington, LLC, Wilmington

Indago Research and Health Center, Hialeah

San Marcus Research Clinic, Inc., Miami

Ocean Blue Medical Research Center, Inc., Miami Springs

The Center for Diabetes and Endocrine Care, Fort Lauderdale

South Florida Research Institute, Lauderdale Lakes

Genesis Clinical Research, Tampa

Innovative Research of West Florida, Inc., Clearwater

Nephrology Consultants, LLC, Huntsville

Knoxville Kidney Center PLLC, Knoxville

Research by Design, LLC, Chicago

Tulane University Hospital and Clinic, New Orleans

Northwest Louisiana Nephrology L.L.C., Shreveport

Research Institute of Dallas, Dallas

Houston Clinical Research Associates, Houston

Science Advancing Medicine Clinical Research Center, San Antonio

Creekside Endocrine Associates, PC, Denver

Boise Kidney and Hypertension Institute, Meridian

California Institute of Renal Research, La Mesa

Office of Dr. Richard S. Cherlin, Los Gatos

SocraTec R&D GmbH, Erfurt

Toronto General Hospital, Toronto

University Hospital Brno, Brno

St. Anna Hospital, 2nd Internal Department, Brno

Institute for Clinical and Experimental Medicine, Prague

General University Hospital in Prague, Prague